<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="abstract"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Eur Psychiatry</journal-id><journal-id journal-id-type="publisher-id">EPA</journal-id><journal-title-group><journal-title>European Psychiatry</journal-title></journal-title-group><issn pub-type="ppub">0924-9338</issn><issn pub-type="epub">1778-3585</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11863115</article-id><article-id pub-id-type="doi">10.1192/j.eurpsy.2024.252</article-id><article-id pub-id-type="other">EPP0012</article-id><article-id pub-id-type="pii">S0924933824002529</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstract</subject></subj-group><subj-group subj-group-type="section"><subject>e-Poster Presentation</subject></subj-group></article-categories><title-group><article-title>The effect of prophylactic esketamine in labor and cesarian delivery on the prevention of postpartum depression (PPD): A systematic review and meta-analysis of randomized controlled trials</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Kozhokar Mikhaylovskaya</surname><given-names>A.</given-names></name><xref rid="aff0424" ref-type="aff">
<sup>1</sup></xref><xref rid="cor0113" ref-type="corresp">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Shimit</surname><given-names>A. Q.</given-names></name><xref rid="aff0425" ref-type="aff">
<sup>2</sup></xref></contrib></contrib-group><aff id="aff0424">
<sup>1</sup>Department of Medicine, <institution>Universitat Internacional de Catalunya</institution>, <city>Sant Cugat del Vall&#x000e8;s</city>, <country>Spain</country></aff><aff id="aff0425">
<sup>2</sup>Department of Medicine, <institution>Pontifical Catholic University of Po&#x000e7;os de Caldas</institution>, <city>Po&#x000e7;os de Caldas</city>, <country>Brazil</country></aff><author-notes><corresp id="cor0113"><label>*</label>Corresponding author.</corresp></author-notes><pub-date publication-format="electronic" date-type="collection" iso-8601-date="2024-04"><month>4</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>27</day><month>8</month><year>2024</year></pub-date><volume>67</volume><issue seq="227">Suppl 1</issue><issue-title content-type="special_issue">Abstracts of the 32nd European Congress of Psychiatry</issue-title><fpage>S103</fpage><lpage>S104</lpage><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (<uri xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S0924933824002529a.pdf"/><abstract><sec id="sec0677"><title>Introduction</title><p>Postpartum depression (PPD) is a common psychiatric illness affecting maternal health, which can lead to poor outcomes for the infant, mother and family. Since the usual pharmacological treatment has low efficacy and a delayed onset of action, new treatment options should be explored. A recent meta-analysis demonstrated positive effects of racemic ketamine on PPD, but limited evidence is available on its more potent derivative esketamine.</p></sec><sec id="sec0678"><title>Objectives</title><p>To determine the effect of esketamine administered prophylactically during labor on the risk of incidence of PPD at 1 week and 6 weeks after delivery.</p></sec><sec id="sec0679"><title>Methods</title><p>PubMed, Scopus and GoogleScholar&#x000a0;databases&#x000a0;were searched for randomized controlled trials that studied the efficacy of esketamine that screened for PPD using the Edinburgh Postpartum Depression Scale (EPDS). Risk ratio was used to determine the effect of incidence on PPD.&#x000a0;Heterogeneity was examined with I2&#x000a0;statistics. A random-effects model was used, as per moderate&#x000a0;heterogeneity&#x000a0;(I2=59%, p-value&#x0003c;0.05).</p></sec><sec id="sec0680"><title>Results</title><p>We included 7&#x000a0;RCTs with 1287 patients, 635 having received esketamine (49.3%). Patient-controlled intravenous analgesia (PCIA) or single intravenous dose during the delivery or cesarian section were the main drug delivery methods. Follow-up ranged from 4 weeks to 6 months, and EPDS cut-off scores for depression risk differed between studies, from 9 to 13 points. Dosages varied from 0.2mg/kg to 0.5mg/kg for single-dose administration and 0.1mg/kg to 1.25mg/kg for PCIA. Incidence of PPD at one week&#x000a0;(RR: 0.459&#x000a0;95%CI 0.217-0.970;&#x000a0;p&#x0003c;0.05; figure 1A) and at 6 weeks&#x000a0;(RR:&#x000a0;0.470&#x000a0;95%CI 0.273-0.810; p&#x0003c;0.01; figure 1B) was&#x000a0;significantly less common in patients who received esketamine during or after labor. Risk of bias was low in 5 studies and moderate in 2 studies. Risk of publication bias is significant.</p><p>
<bold>Image:</bold>
</p><p>
<fig position="float" id="fig0002"><graphic xlink:href="S0924933824002529-FIG0002" position="anchor"/></fig>
</p></sec><sec id="sec0681"><title>Conclusions</title><p>Prophylactic esketamine seems to improve EPDS scores in women at one and six weeks after birth. A more thorough analysis of the adverse effects on maternal and neonatal health are required, and long-term benefits are not fully understood. Larger multicenter studies would be a welcome addition to the issue at hand.</p></sec><sec id="sec0682"><title>Disclosure of Interest</title><p>None Declared</p></sec></abstract><counts><page-count count="2"/></counts></article-meta></front></article>